摘要
目的分析在阴道分娩产后出血预防中,应用卡孕栓塞肛联合缩宫素干预的临床效果。方法选择2018年5月—2021年8月该院收治的52例经阴道分娩产妇为研究对象,依据随机数表法将其分为两组,采取缩宫素静脉滴注治疗的22例纳入对照组,采取卡孕栓塞肛联合缩宫素静脉滴注治疗的30例纳入观察组。对比两组产后出血发生率、产后出血量、生命体征及不良反应发生率。结果观察组产后2 h、24 h出血发生率为0.00%、3.33%,低于对照组的22.73%、31.82%,差异有统计学意义(χ^(2)=5.155、5.874,P<0.05)。观察组产后2 h、24 h出血量为(252.64±48.75)、(387.22±65.48)mL,均少于对照组的(355.28±85.46)、(478.56±94.36)mL,差异有统计学意义(t=5.484、4.124,P<0.05)。观察组分娩后血压(收缩压、舒张压)及血氧饱和度(SaO_(2))对比对照组,差异无统计学意义(t=0.401、0.285、1.688,P>0.05)。观察组不良反应发生率为6.67%,与对照组13.64%对比,差异无统计学意义(χ^(2)=0.134,P>0.05)。结论在阴道分娩产后出血预防中,联合应用卡孕栓塞肛和缩宫素效果显著,可有效减少产妇分娩后出血量,稳定产妇生命体征,且药物不良反应小,安全性高,值得推广。
Objective To analyze the clinical effect of the application of carpron anus embolization combined with oxytocin intervention in the prevention of postpartum hemorrhage in vaginal delivery.Methods 52 cases of vaginal delivery women admitted to the hospital from May 2018 to August 2021 were selected as the research objects.According to the random number table method,they were divided into two groups,22 cases treated with oxytocin intravenous drip were included in the control group,and 30 cases treated with carpron anal embolization combined with oxytocin intravenous drip treatment were included in the observation group.The incidence of postpartum hemorrhage,postpartum hemorrhage volume,vital signs and incidence of adverse reactions were compared between the two groups.Results The incidence of postpartum hemorrhage in the observation group was 0.00%and 3.33%,which were lower than 22.73%and 31.82%in the control group,and the difference was statistically significant(χ^(2)=5.155,5.874,P<0.05).The postpartum hemorrhage volume of the observation group was(252.64±48.75)mL,(387.22±65.48)mL,which were less than(355.28±85.46)mL,(478.56±94.36)mL of the control group,and the difference was statistically significant(t=5.484,4.124,P<0.05).The blood pressure(systolic blood pressure,diastolic blood pressure)and blood oxygen saturation(SaO_(2))between the observation group and the control group after delivery,the difference was not statistically significant(t=0.401,0.285,1.688,P>0.05).The incidence of adverse reactions in the observation group was 6.67%,compared with the control group 13.64%,the difference was not statistically significant(χ^(2)=0.134,P>0.05).Conclusion In the prevention of postpartum hemorrhage in vaginal delivery,the combined application of carborigin embolization and oxytocin has a significant effect,which can effectively reduce the amount of postpartum hemorrhage and stabilize maternal vital signs,and the side effects of the drug are small,the safety is high,and it is worthy of promotion.
作者
戚志雯
QI Zhiwen(Department of Obstetrics and Gynecology,Xuzhou Mining Hospital,Xuzhou,Jiangsu Province,221102 China)
出处
《系统医学》
2022年第9期167-170,共4页
Systems Medicine
关键词
阴道分娩
产后出血
卡孕栓塞肛
缩宫素
出血量
不良反应
Vaginal delivery
Postpartum hemorrhage
Anal embolization by carprena
Oxytocin
Bleeding volume
Adverse reactions
